Susan Berson and Brent Henry Recognized as Health Care Trailblazers by the National Law Journal

Mintz Member Jennifer Kiely was featured in a Q&A for Law.com’s “How I Made Partner” series, which features conversations with legal industry leaders about how they climbed the ladder of success and what they learned along the way. In the profile, Ms. Kiely discussed the importance of being able to identify, understand and anticipate a client's most important needs, having a good mentor to provide the tools, support, and feedback you need to thrive in your career, and, how with discipline and focus, obstacles will never hold you back.

Mintz served as health regulatory legal advisor to Kindred Healthcare in the recently completed sale of Kindred Healthcare to LifePoint Health, a national network of hospitals, post-acute service providers, and outpatient centers. As a result of the successful transaction, ScionHealth, a new healthcare system focused on high-quality acute and post-acute hospital solutions, was launched on December 23rd.

In an article published by Law360 Pulse, Mintz Director of Diversity, Equity, and Inclusion Narges Kakalia discussed the importance of law firms facilitating psychological safety in the workplace in order to retain minority lawyers.

Mintz Member and Chair of the firm’s Intellectual Property Litigation Practice Matthew Hurley, Member and Chair of the firm’s Intellectual Property Division Michael Renaud, and Associate Oliver Ennis co-authored an article published in the November/December 2021 issue of IP Litigator exploring why arbitration has become an increasingly attractive alternative for resolving IP disputes. The authors wrote that while arbitration isn’t the right fit (or even available) in all situations, IP rights holders should consider adding it to their enforcement strategies.

Mintz Member and Chair of the firm’s Intellectual Property Division Michael Renaud was quoted extensively in an article published by Law360 examining the potential impact for standard-essential patent (SEP) owners of the U.S. Department of Justice’s and the U.S. Patent and Trademark Office’s draft policy statement concerning licensing negotiations and remedies for SEPs subject to voluntary F/RAND commitments.